Palobiofarma Overview

  • Founded
  • 2006
Founded
  • Status
  • Private
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $2.21M
Latest Deal Amount
  • Investors
  • 7

Palobiofarma General Information

Description

Provider of drug discovery and development services based on the modulation of adenosine receptors. The company focuses to discover the first marketed drug based on a selective adenosine receptor modulator leveraging medicinal chemistry and in vitro pharmacology of adenosine, enabling doctors to focus on the treatment of advanced prostate cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • Avenida Ernest Lluch 32
  • TCM3, planta 4, puerta 1, Mataro
  • 08302 Barcelona
  • Spain
+34 936 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Palobiofarma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 26-Sep-2019 $2.21M 000.00 Completed Clinical Trials - Phase 2
4. Later Stage VC 20-Jun-2013 00.000 000.00 Completed Clinical Trials - Phase 2
3. Later Stage VC 01-Mar-2012 00.000 00.000 Completed Startup
2. Grant 01-Jan-2011 $2.9M Completed Startup
1. Early Stage VC 01-Jan-2010 $2.9M $2.9M Completed Startup
To view Palobiofarma’s complete valuation and funding history, request access »

Palobiofarma Executive Team (3)

Name Title Board Seat Contact Info
Julio Castro-Palomino Laria Co-Founder & Chief Executive Officer
Juan Camacho Gamez Co-Founder, Chief Science Officer & Chemist
Lyhen González Chief Financial Officer
To view Palobiofarma’s complete executive team members history, request access »

Palobiofarma Board Members (1)

Name Representing Role Since
Josep Echarri Inveready Technology Investment Group Board Member 000 0000
To view Palobiofarma’s complete board members history, request access »

Palobiofarma Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Sociedad de Desarrollo de Navarra Venture Capital Minority 000 0000 000000 0
Everis Group Corporation Minority 000 0000 000000 0
Fitalent Corporate Venture Capital Minority 000 0000 000000 0
Genome Spain Venture Capital Minority 000 0000 000000 0
European Union Government 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »